Cancer Res 82:CT108CT108 Schuhmacher J, Heidu S, Balchen T, Richardson JR, Schmeltz C, Sonne J, Schweiker J, Rammensee HG, Thor Straten P et al (2020) Vaccination against RhoC induces long-lasting immune responses in patients with prostate cancer: results from a phase I/II clinical trial
Before starting Ask yourself whether the potential benefits justify the commitment
Johnson JB, John S, Laub DR
Here is why that matters
Many cheaper alternatives may contain diluted or ineffective version of the peptide
In vitro investigations suggested that AOD 9604 may promote the differentiation of adipose-derived mesenchymal stem cells into osteogenic lineages in laboratory models, potentially supporting bone regeneration research